The report provides a detailed analysis essential for establishing a Mefenamic Acid production plant. It encompasses all critical aspects necessary for Mefenamic Acid production, including the cost of Mefenamic Acid production, Mefenamic Acid plant cost, Mefenamic Acid production costs, and the overall Mefenamic Acid production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Mefenamic Acid production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Mefenamic Acid is a steroid-free analgesic drug that finds huge applications in the pharmaceutical industry. The compound is mainly utilized for the treatment of inflammation, fever, and various mild to moderate pain conditions in the body, Moreover, it finds its application in alleviating abdominal pain, toothaches, migraines, and headaches. It is often applied in the treatment of gout attacks. Additionally, it is also employed as a medication to reduce pain and blood loss from menstrual conditions.
The market for Mefenamic Acid is primarily driven by its application as a short-term analgesic for alleviating mild to moderate pain in the body, which significantly boosts its demand in the medical and pharmaceutical industry. Moreover, its usage as a medication for the treatment of pain associated with various body conditions, such as osteoarthritis, dysmenorrhea, and migraines, further contributes to its demand in the medical and healthcare industries. In general, several factors, such as the availability of raw materials (2,3-dimethylaniline, etc.), cost, their broad applications in the pharmaceutical industry, and maintaining quality standards, significantly influence industrial Mefenamic Acid procurement globally.
Raw Material for Mefenamic Acid Production
According to the Mefenamic Acid production plant project report, the major raw material for Mefenamic Acid production include 2-Chlorobenzoic Acid-2,3-Dimethylaniline.
Production Process of Mefenamic Acid
The extensive Mefenamic Acid production cost report consists of the following industrial production process:
- Production via Condensation: This method of production involves the process of catalytic condensation by using copper as a catalyst to produce Mefenamic Acid as the product. The process is initiated by the reaction of 2-chlorobenzoic acid (CBA) and 2,3-dimethylaniline (DMA) in the presence of copper (II) acetate as a catalyst, which results in the formation of Mefenamic Acid as the final product.
Mefenamic Acid is a form of NSAID drug that is available in the form of oral capsules. It is primarily marketed under the brand name Ponstel. The IUPAC name of the compound is 2-(2,3-dimethylanilino)benzoic acid. Moreover, the molecular formula of the compound is C15H15NO2, and its molar mass is 241.28 g/mol. The compound appears as an odorless, whitish, pale-yellow solid that does not dissolve in water but is slightly soluble in ethanol and methylene chloride.
Additionally, the boiling point of the compound is 384.06°C, and its melting point is 230 °C. Its density is 1.0944 g/cm3, and the value of dissociation constant (pka) is 4.2(at 25 °C). The compound is observed to be hepatotoxic and may cause potential renal toxicity.
